| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.0M | -4.8% | +434.0% |
| R&D Expense | $0 | — | — |
| SG&A Expense | $3.0M | -31.4% | +5.3% |
| Operating Income | -$5.9M | +7.7% | -5.5% |
| Income Tax | $0 | — | — |
| Net Income | -$6.6M | +10.9% | +41.5% |
| EPS (Basic) | -$2.60 | -900.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.5M | +106.2% | +88.4% |
| Accounts Receivable | $1.1M | -51.9% | +175.9% |
| Inventory | $915K | +0.2% | -59.0% |
| Current Assets | $9.6M | +20.4% | +31.1% |
| Total Assets | $42.8M | +2.2% | +71.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.9M | — | — |
| Capital Expenditures | $48K | — | — |
| Investing Cash Flow | -$3.9M | — | — |
| Financing Cash Flow | $27.2M | — | — |
| Free Cash Flow | -$19.0M | — | — |
| +38.7% |
| EPS (Diluted) | -$2.60 | -900.0% | +38.7% |
| $46.5M |
| +153.9% |
| +253.9% |
| Long-term Debt | $30.0M | +8.5% | -34.9% |
| Total Liabilities | $46.9M | -1.3% | -23.7% |
| Stockholders' Equity | -$4.1M | +27.4% | +88.7% |